{"id":"W1935342590","doi":"10.3310/hta19780","title":"A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)","year":2015,"lang":"en","type":"article","venue":"Health Technology Assessment","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Cilag; Medical Research Council; Evidence Synthesis Programme; Allergan; Aston University; Pfizer; University of Pittsburgh; Queen's University; Health Technology Assessment Programme; Queen's University Belfast; National Institute for Health and Care Research","keywords":"Ranibizumab; Medicine; Bevacizumab; Macular degeneration; Diabetic retinopathy; Pegaptanib; Visual acuity; Ophthalmology; Regimen; Clinical trial; Randomized controlled trial; Cost effectiveness; Optometry; Surgery; Internal medicine; Diabetes mellitus; Chemotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01128,0.003389405,0.006624694,0.001113734,0.0009344461,0.002143397,0.001967656,0.005574446,0.02200919],"category_scores_gemma":[0.01722449,0.001445025,0.004961798,0.001057794,0.003016169,0.003435757,0.001408594,0.004597598,0.00187143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002707913,"about_ca_system_score_gemma":0.003584273,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002050421,"about_ca_topic_score_gemma":0.002199581,"domain_scores_codex":[0.9890609,0.007788592,0.0008180508,0.001195423,0.000499735,0.000637355],"domain_scores_gemma":[0.9881834,0.006121035,0.002500027,0.0008601232,0.0006754108,0.001659828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9940789,0.001533458,0.0001225072,0.0006782523,0.0007769904,0.00002317094,0.0000195214,0.0001564588,0.0001406802,0.0001337151,0.0001715056,0.002164871],"study_design_scores_gemma":[0.9839835,0.01490946,0.0001494,0.000056801,0.0003438926,0.00001077439,0.0000071384,0.0001805339,0.00002784472,0.0001443676,0.0001799269,0.000006368733],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8456517,0.02256812,0.005416641,0.004072693,0.008790459,0.09976058,0.004359318,0.0003751454,0.009005208],"genre_scores_gemma":[0.8770173,0.004287459,0.007934933,0.003125226,0.001644706,0.09924417,0.001555165,0.0000353945,0.00515572],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02200919,"threshold_uncertainty_score":0.07362807,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09060190211912343,"score_gpt":0.4689941303897434,"score_spread":0.37839222827062,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}